Association Between Preoperative Osteopenia and Prognosis in Breast Cancer Patients
- Sachie Omori 1,2, Hideki Ijichi 3,2, Ayako Wakasugi 3,2, Tomoko Shigechi 3,2, Eiji Oki 3, Makoto Kubo 2, Tomoharu Yoshizumi 3
- Sachie Omori 1,2, Hideki Ijichi 3,2, Ayako Wakasugi 3,2
- 1Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; omori.sachie12@gmail.com.
- 2Department of Breast Surgery, Kyushu University, Fukuoka, Japan.
- 3Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- 0Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; omori.sachie12@gmail.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Preoperative osteopenia, a loss of bone mineral density, is linked to increased breast cancer recurrence, especially in premenopausal women. This finding highlights osteopenia as a significant prognostic factor for breast cancer survival.
Area Of Science
- Oncology
- Radiology
- Bone Metabolism
Background
- Osteopenia, characterized by reduced bone mineral density (BMD), is an emerging prognostic factor in various cancers.
- The prognostic role of preoperative osteopenia in breast cancer patients is not well-established.
- Clarifying this association is crucial for improving breast cancer patient outcomes.
Purpose Of The Study
- To investigate the clinical significance of preoperative osteopenia as a prognostic factor in primary breast cancer.
- To determine the relationship between osteopenia and patient survival, considering menopausal status.
Main Methods
- Retrospective analysis of 532 primary breast cancer patients (Stage I-III) diagnosed between 2009 and 2017.
- Osteopenia assessment using average pixel density (Hounsfield unit) in the 11th thoracic vertebra on preoperative CT scans.
- Evaluation of recurrence-free survival (RFS) and overall survival (OS) in relation to osteopenia status and menopausal status.
Main Results
- Osteopenia was present in 35.0% of patients.
- Patients with osteopenia had significantly worse RFS (p=0.0275) but not OS.
- In premenopausal patients, osteopenia was associated with significantly worse RFS and OS (p=0.0094 and p=0.0264, respectively) and was an independent prognostic factor for RFS (p=0.0266).
Conclusions
- Preoperative osteopenia is independently associated with an increased risk of breast cancer recurrence.
- The prognostic impact of osteopenia is particularly significant in premenopausal breast cancer patients.
- These findings suggest that osteopenia assessment may aid in risk stratification for breast cancer recurrence.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:29
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:21
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

